Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
STAMFORD, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its Board...
-
Allows USAR to Begin Fulfilling Customer Orders in 2Q26, With Further Capacity Expansion to Follow Critical Step in USAR’s Effort to Secure, Reshore and Grow a Globally Integrated Rare Earth Value...
-
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026Lead clinical candidate IND filing in...
-
Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected to reach target enrollment (n=300) in April 2026, with topline results expected in the third quarter of 2026Phase 2 IRIS trial for ML-004...
-
ST. GALLEN, Switzerland, March 26, 2026 (GLOBE NEWSWIRE) -- Sportradar AG (NASDAQ: SRAD) today announced it has deepened its multi-year agreement with Hard Rock Bet, adding official PGA TOUR and...
-
Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for craniofacial pain conditions, including migraine and...
-
Five Diversified, Ramping DeFi Business Lines Delivered Growth Exceeding Q4 Guidance Treasury Exceeds 1.93M HYPE, 1.92M KNTQ, & 1.00M HPL Tokens as of March 23(14) HYPD’s Unique “Triple-Dip”...
-
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
-
Iconic Popsicle® Flavors Reimagined as Ready-to-Drink Hard Beverages Through New Licensing Agreement NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the...
-
Agomab today announced that the USPTO granted a patent covering the composition of matter of AGMB-447.